Lenalidomide Hydrate (5 Mg/40 Capsules/1 Case) 1 Tender - 151805604

The NATIONAL UNIVERSITY CORPORATION - MIYAGI has issued a Tender notice for the procurement of a Lenalidomide Hydrate (5 Mg/40 Capsules/1 Case) 1 Set, And 13 other Contracts in the Japan. This Tender notice was published on 31 Oct 2026 and is scheduled to close on 16 Mar 2026, with an estimated Tender value of Refer Document. Interested bidders can access detailed Tender information, eligibility criteria, and complete bidding documents by referencing TOT Ref No. 151805604, while the tender notice number is and Registering on the platform.

Expired Tender

Procurement Summary

Country: Japan

Summary: Lenalidomide Hydrate (5 Mg/40 Capsules/1 Case) 1 Set, And 13 other Contracts

Deadline: 16 Mar 2026

Posting Date: 31 Oct 2026

Other Information

Notice Type: Tender

TOT Ref.No.: 151805604

Document Ref. No.:

Competition: ICB

Financier: Self Financed

Purchaser Ownership: Public

Tender Value: Refer Document

CPV Classification

33600000 - Pharmaceutical products

Purchaser's Detail

Name: Login to see tender_details

Address: Login to see tender_details

Email: Login to see tender_detailsLogin to see details

Tender Details

Lenalidomide Hydrate (5 mg/40 Capsules/1 case) 1 Set, and 13 other contracts
Classification: 0004 Medical & Pharmaceutical Products

Summay of Notice: ⑴ Official in charge of disbursement of the procuring entity : Hitoshi Izu, Vice President, Tohoku University ⑵ Classification of the products to be procured : 4 ⑶ Nature and quantity of the products to be purchased : A Lenalidomide Hydrate (5 mg/40 Capsules/1 case) 1 Set B Satralizumab (Genetical Recombination) (120 mg/1 ㎖/1 vial) 1 Set C Tisagenlecleucel 1 Set D Axicabtagene ciloleucel 1 Set E Idecabtagene vicleucel 1 Set F Asfotase Alfa (Genetical Recombination) (40 mg/1 ㎖/1 vial) 1 Set G Asfotase Alfa (Genetical Recombination) (80 mg/0.8 ㎖/1 vial) 1 Set H Onasemnogene abeparvovec 1 Set I Viltolarsen (250 mg/5 ㎖/1 vial) 1 Set J Lisocabtagene maraleucel 1 Set K Dinutuximab (Genetical Recombination) (17.5 mg/5 ㎖/1 vial) 1 Set L Ravulizumab (Genetical Recombination) (300 mg/3 ㎖/1 vial) 1 Set M Inebilizumab (Genetical Recombination) (100 mg/10 ㎖/3 vials/1 case) 1 Set ⑷ Delivery period : From 1 April, 2026 through 31 March, 2027 ⑸ Delivery place : Tohoku University Hospital ⑹ Qualifications for participating in the tendering procedures : Suppliers eligible for participating in the proposed tender are those who shall : A The same as the notice above No.107. B have the following Grade qualification, for each item in 5⑶ above, ACDEFGHIJKLM have the Grade A, Grade B, or Grade C qualification during fiscal 2025 in the Tohoku area in sales of product for participating in tenders by Single qualification for every ministry and agency, or in tenders by Tohoku University, B have the Grade A, Grade B, Grade C or Grade D qualification during fiscal 2025 in the Tohoku area in sales of product for participating in tenders by Single qualification for every ministry and agency, or in tenders by Tohoku University, C prove to have obtained the wholesalers in accordance with the Law on Securing Quality, Efficacy and Safety of Products including Pharmaceuticals and Medical Devices, D The same as the notice above...

Documents

 Tender Notice


Similar Tenders

Request Demo
GiZ Tenders India

Procurement Documents for Japan

Access a comprehensive library of standard procurement documents specific to Japan. Here, you'll find all the essential forms, guidelines, and templates required for tender applications and submissions in Japan

Explore Procurement Documents for Japan


Want To Bid in This Tender?

Get Local Agent Support in Japan and 60 More Countries.

View All The Services


View Tenders By


Publish Tenders


Have Any Dispute With The Purchaser?